Role of myeloid-derived suppressor cells in tumor immunotherapy. - Wikidata - awgldk - TriplyDB

Role of myeloid-derived suppressor cells in tumor immunotherapy.

Role of myeloid-derived suppressor cells in tumor immunotherapy.

http://www.wikidata.org/entity/Q37965750

about

Immunotherapy for lung cancer: advances and prospects Update on the challenges and recent advances in cancer immunotherapy Vaccines versus immunotherapy: overview of approaches in deciding between options Rad52 deficiency decreases development of lung squamous cell carcinomas by enhancing immuno-surveillance.MicroRNA-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth.Review article: antitumoural immunity in colorectal cancer - current and potential future implications in clinical practice.Chronic inflammation and cancer: suppressing the suppressors.Novel avenues in immunotherapies for colorectal cancer.Myeloid-derived suppressor cells in gastrointestinal cancers: A systematic review.Chronic hepatitis B surface antigen seroclearance-related immune factors.GM-CSF signalling blockade and chemotherapeutic agents act in concert to inhibit the function of myeloid-derived suppressor cells in vitro.Poly (I:C) enhances the anti-tumor activity of canine parvovirus NS1 protein by inducing a potent anti-tumor immune response.Daunorubicin conjugated with alpha-fetoprotein selectively eliminates myeloid-derived suppressor cells (MDSCs) and inhibits experimental tumor growth.Myeloid-derived suppressor cells can be efficiently generated from human hematopoietic progenitors and peripheral blood monocytes.

P2860

Q26750617-32CF596E-ACCE-4243-90C9-6D6D54C785B4 Q27014693-9F2807AE-631A-42C5-AD09-3CF513C5D7B8 Q28085434-BAACE12E-6CA6-4262-99B5-54BAB846FD12 Q33798257-8644291C-F434-4C5C-9291-E83F23AA9181 Q34899627-DA028B8A-3AA5-41D1-8AFB-B5170C673543 Q38108366-CF50A049-2ED0-406A-963F-16192DD6EE4E Q38132688-84D1F4B5-9CA0-44B1-A930-AB6B29F2946C Q38637906-27A42F08-F8D8-432B-A191-AFC267E777B5 Q38686288-5EA9B551-360C-453A-A4A3-69F8A180B7D0 Q38809744-761B78EA-B9E0-45F2-AFAF-0B3B6996BD35 Q40032613-AC0D5394-E52D-4C8E-A7E9-2BC7042EB83B Q40516283-730D4F36-A6BE-4A70-9EAC-311533915AB8 Q47804533-F3AC3ACB-3F08-4B23-8D09-99B2C81AFEFB Q52923090-4A25C8EE-CFA1-4795-A5BB-B476EC0EBE88

P2860

Role of myeloid-derived suppressor cells in tumor immunotherapy.

http://www.wikidata.org/entity/Q37965750

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Role of myeloid-derived suppressor cells in tumor immunotherapy.

@en

Role of myeloid-derived suppressor cells in tumor immunotherapy.

@nl

type

label

Role of myeloid-derived suppressor cells in tumor immunotherapy.

@en

Role of myeloid-derived suppressor cells in tumor immunotherapy.

@nl

prefLabel

Role of myeloid-derived suppressor cells in tumor immunotherapy.

@en

Role of myeloid-derived suppressor cells in tumor immunotherapy.

@nl

P1433

Q37965750-78077C2D-3904-4B7E-A778-904A97BCDC7C

P1476

Q37965750-673E95FA-0A16-4204-8C10-B29AA0883DF7

P2860

Q37965750-03230083-6CD6-41B9-943D-D2276DBDD298

Q37965750-06817E21-D841-4609-AA31-A89861CBC012

Q37965750-08FB8777-38FC-4F4A-913A-D5E0CCFCBD6D

Q37965750-0BB89425-6710-4A8D-B1B4-75DCAADCFFBF

Q37965750-0FC16295-E633-4207-8114-3FF0E9EEB8C4

Q37965750-11EB6303-5A08-420A-AEA5-98B12082EFC8

Q37965750-16700CBB-229B-4637-87D8-7456CE990313

Q37965750-1830E5BB-8889-4790-92B5-9412CBFD031B

Q37965750-1B58B93A-883B-4950-8D95-F54D85C55C84

Q37965750-1F708F53-F805-4982-828D-E4E2C0C39AB9

P304

Q37965750-2390D3E4-F513-45BB-9C86-A6E0FE635E5F

P31

Q37965750-45E766D0-8A0F-4517-8E3D-B624066F5B22

P356

Q37965750-63358D9A-5059-4167-8890-212309210266

P433

Q37965750-2C142C37-5E4E-44A5-83A5-BA7C93277163

P478

Q37965750-BF370BD7-E373-421A-AF87-ED457018D745

P50

Q37965750-3BD2E587-D3EE-493D-9C9D-A8C50F3BBD55

Q37965750-ADEA5638-9A60-4333-924F-3DC54BB9F204

Q37965750-B0AC33AE-3735-445E-B491-6B5C90CF9A97

P577

Q37965750-01ED7705-8DFA-4856-8497-C2D9F5A5B592

P698

Q37965750-B58D3BD6-0DA4-453E-B07D-6FD1B14A58A5

P921

Q37965750-2BEB201D-CE65-414D-AFB2-D74652588093

P356

P1433

P1476

Role of myeloid-derived suppressor cells in tumor immunotherapy.

@en

P2860

Myeloid-derived suppressor cells: linking inflammation and cancer

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Myeloid-derived suppressor cells as regulators of the immune system

Calreticulin exposure dictates the immunogenicity of cancer cell death

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

Macrophage activation and polarization

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.

P304

43-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/IMT.11.154

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

François Ghiringhelli

François Martin

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22150000

http://www.w3.org/2001/XMLSchema#string

P921